Yi X - Search Results

1

Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.

Pan Y, Zhang JT, Gao X, Chen ZY, Yan B, Tan PX, Yang XR, Gao W, Gong Y, Tian Z, Liu SM, Lin H, Sun H, Huang J, Liu SY, Yan HH, Dong S, Xu CR, Chen HJ, Wang Z, Li P, Guan Y, Wang BC, Yang JJ, Tu HY, Yang XN, Zhong WZ, Xia X, Yi X, Zhou Q, Wu YL. Pan Y, et al. Among authors: yi x. Cancer Cell. 2023 Oct 9;41(10):1763-1773.e4. doi: 10.1016/j.ccell.2023.09.007. Cancer Cell. 2023. PMID: 37816331

2

Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing.

Huang J, Zhao G, Peng Q, Yi X, Ji L, Li J, Li P, Guan Y, Ge J, Chen L, Chen R, Hu X, Lee WC, Reuben A, Futreal PA, Xia X, Ma J, Zhang J, Chen Z. Huang J, et al. Among authors: yi x. Mol Oncol. 2023 Aug;17(8):1531-1544. doi: 10.1002/1878-0261.13381. Epub 2023 Mar 7. Mol Oncol. 2023. PMID: 36703611 Free PMC article.

3

Stratification of non-small cell lung adenocarcinoma patients with EGFR actionable mutations based on drug-resistant stem cell genes.

Xie X, Li L, Xie L, Liu Z, Zhang G, Gao X, Peng W, Deng H, Yang Y, Yang M, Chang L, Yi X, Xia X, He Z, Zhou C. Xie X, et al. Among authors: yi x. iScience. 2023 Apr 8;26(6):106584. doi: 10.1016/j.isci.2023.106584. eCollection 2023 Jun 16. iScience. 2023. PMID: 37288343 Free PMC article.

4

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.

Zheng X, Lin J, Xiong J, Guan Y, Lan B, Li Y, Gao X, Fei Z, Chen L, Chen L, Chen L, Chen G, Guo Z, Yi X, Cao W, Ai X, Zhou C, Li X, Zhao J, Yan X, Yu Q, Si L, Chen Y, Chen C. Zheng X, et al. Among authors: yi x. BMC Cancer. 2023 Jul 21;23(1):686. doi: 10.1186/s12885-023-10920-4. BMC Cancer. 2023. PMID: 37479966 Free PMC article.

5

DELFMUT: duplex sequencing-oriented depth estimation model for stable detection of low-frequency mutations.

Wu G, Song M, Wang K, Cui T, Jiao Z, Ji L, Gao X, Wang J, Liu T, Xia X, Fang H, Guan Y, Yi X. Wu G, et al. Among authors: yi x. Brief Bioinform. 2023 Sep 20;24(5):bbad277. doi: 10.1093/bib/bbad277. Brief Bioinform. 2023. PMID: 37539831

6

Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.

Zeng L, Zhou Y, Xu Q, Huang Z, Song L, Wang Z, Deng L, Wu Y, Liang Y, Liu Z, Gao X, Yi X, He Q, Xia X, Yang H, Zhang X, Yan H, Qin H, Lin S, Yang N, Zhang Y. Zeng L, et al. Among authors: yi x. Lung Cancer. 2023 Oct;184:107350. doi: 10.1016/j.lungcan.2023.107350. Epub 2023 Aug 28. Lung Cancer. 2023. PMID: 37659241

7

Prognostic and predictive impact of molecular tumor burden index in non-small cell lung cancer patients.

Yang F, Tang M, Cui L, Bai J, Yu J, Gao J, Nie X, Li X, Xia X, Yi X, Zhang P, Li L. Yang F, et al. Among authors: yi x. Thorac Cancer. 2023 Nov;14(31):3097-3107. doi: 10.1111/1759-7714.15098. Epub 2023 Sep 19. Thorac Cancer. 2023. PMID: 37724484 Free PMC article.

8

Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues.

Hu Q, Frank ML, Gao Y, Ji L, Peng M, Chen C, Wang B, Hu Y, Wu Z, Li J, Shu L, He Q, Zhang Y, Xia X, Zhang J, Yi X, Reuben A, Yu F. Hu Q, et al. Among authors: yi x. Oncoimmunology. 2023 Oct 20;12(1):2233399. doi: 10.1080/2162402X.2023.2233399. eCollection 2023. Oncoimmunology. 2023. PMID: 37876834 Free PMC article.

9

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).

Zhang JT, Dong S, Gu WQ, Zhao N, Liang Y, Tang WF, Liu SY, Wang F, Wang GS, Peng B, Wu N, Yan S, Geng GJ, Xie ZF, Yang YL, Zhang JH, Zhang T, Yang N, Jiao WJ, Xiong YY, Cai M, Li F, Chen RR, Yan HH, Maggie Liu SY, Yi X, Zhong WZ, Yang XN, Wu YL. Zhang JT, et al. Among authors: yi x. Clin Lung Cancer. 2024 Jan;25(1):e1-e4. doi: 10.1016/j.cllc.2023.09.008. Epub 2023 Oct 6. Clin Lung Cancer. 2024. PMID: 37880076 Clinical Trial.

10

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.

Han J, Dong Y, Zhu X, Reuben A, Zhang J, Xu J, Bai H, Duan J, Wan R, Zhao J, Bai J, Xia X, Yi X, Cheng C, Wang J, Wang Z. Han J, et al. Among authors: yi x. Nat Commun. 2024 Feb 8;15(1):1199. doi: 10.1038/s41467-024-45361-5. Nat Commun. 2024. PMID: 38331912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,339 results

Search Page